EGR2 and renal cell adenocarcinoma: Interestingly, a study has also reported that EGR2 could increase IGF2BPs expression to enhance the m6A level of sphingosine-1-phosphate receptor 3 to accelerate tumorigenesis and metastasis of renal cell cancer (Ying et al., 2021).